Drug profile · INN
nortriptyline hydrochloride
NORTRIPTYLINE HYDROCHLORIDE
nortriptyline hydrochloride (NORTRIPTYLINE HYDROCHLORIDE) is a norepinephrine transporter inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — nortriptyline hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
nortriptyline hydrochloride (NORTRIPTYLINE HYDROCHLORIDE) is a norepinephrine transporter inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Norepinephrine transporter inhibitor
Primary target: Sodium-dependent noradrenaline transporter
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is nortriptyline hydrochloride?
nortriptyline hydrochloride (NORTRIPTYLINE HYDROCHLORIDE) is a norepinephrine transporter inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for nortriptyline hydrochloride?
NORTRIPTYLINE HYDROCHLORIDE is a marketed brand name for nortriptyline hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of nortriptyline hydrochloride?
nortriptyline hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.